Endocrinology

Top Story

FDA: DPP-IV inhibitors may cause severe joint pain

August 28, 2015

The FDA recently a warned that the medications Januvia, Onglyza, Tradjenta and Nesina may cause joint pain that is severe and disabling, according to a press release.

It said, however, that patients should not change or stop their medications without talking to their physician. Health care providers of patients on Januvia (sitagliptin, Merck), Onglyza (saxagliptin, AstraZeneca), Tradjenta (linagliptin, Boehringer-Ingelheim) or Nesina (alogliptin, Takeda) should discontinue these DPP-IV inhibitors if appropriate.

In the Journals

Growth hormone reduces osteoporotic fracture risk in older women

August 28, 2015
Older women with osteoporosis treated with growth hormone showed a reduced risk for fracture and improved bone density that continued for years after stopping treatment…
FDA News

FDA approves Synjardy for type 2 diabetes

August 28, 2015
The FDA has approved Synjardy to control blood glucose levels in adults with type 2 diabetes, according to a release from Boehringer Ingelheim Pharmaceuticals and Eli…
FDA News

FDA: Lots of OmniPod insulin management system recalled

August 28, 2015
In early July, Insulet Corporation initiated a voluntary recall of 40,846 boxes of the OmniPod Insulin Management System, according to an FDA press release.It was…
FDA News

FDA approves evolocumab as LDL-lowering therapy in certain patients

August 27, 2015
The FDA has approved evolocumab, a PCSK9 inhibitor, for lowering LDL in adults with heterozygous or homozygous familial hypercholesterolemia or clinical atherosclerotic…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and…
More »
Meeting News Coverage Video
VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

August 10, 2015
NEW ORLEANS — Chef Leah Sarris, program director at the Goldring Center for Culinary Medicine at Tulane…
More »
CME
Managing Today's EP Challenges with NOAC Use

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan